Drug Database
Back to search

Belgium· BE-AMP-SAM514817-00

Tovedeso 7 mg

A desfesoterodin product containing desfesoterodine succinate, registered in Belgium by Teva.

ATC G04BD13

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedTovedeso 7 mgATCG04BD13REGISTER NO.BE-AMP-SAM514817-00PACKS LISTED3CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about desfesoterodine succinateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Desfesoterodine Succinate
Manufacturer
Teva
Country
Belgium (BE)
ATC code
G04BD13
ATC class
Desfesoterodin
Defined daily dose
3.5 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

2 priced
  • be_apb
    3885332
    EUR 29.18
  • be_apb
    3885340
    EUR 71.63
  • be_apb
    7724347

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Desfesoterodin in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All desfesoterodin products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Germany · Tovedeso
  • Spain · Tovedeso
  • Croatia · Tovedeso

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c7e51187-6de4-4208-aeb0-99a177835c80
GET /v1/drugs/c7e51187-6de4-4208-aeb0-99a177835c80?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Prolonged-release tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Tovedeso 7 mg",
  "name_fr": "Tovedeso 7 mg",
  "name_nl": "Tovedeso 7 mg",
  "amp_code": "SAM514817-00",
  "strengths": [
    "7.0000",
    "7.0000",
    "5.2000",
    "5.2000",
    "1.2500"
  ],
  "pack_count": 7,
  "substances": [
    "Desfesoterodine Succinate",
    "Desfesoterodine",
    "Glycerol 85%"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Desfesoterodine",
  "authorisation_numbers": [
    "BE514817"
  ]
}
API referenceMCP serverPlans

See everything about desfesoterodin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console